Literature DB >> 25940253

The effect of OSA on work disability and work-related injuries.

A J Marcus Hirsch Allen1, Nick Bansback2, Najib T Ayas3.   

Abstract

OSA is a common yet underdiagnosed respiratory disorder characterized by recurrent upper airway obstruction during sleep. OSA results in sleep fragmentation and repetitive hypoxemia and is associated with a variety of adverse consequences including excessive daytime sleepiness, reduced quality of life, cardiovascular disease, decreased learning skills, and neurocognitive impairment. Neurocognitive impairments that have been linked to poor sleep include memory deficits, decreased learning skills, inability to concentrate, and decreased alertness. Furthermore, the societal and economic costs of OSA are substantial; for example, patients with OSA have a significantly greater risk of motor vehicle crashes, consume more health-care resources, and have associated annual costs in the billions of dollars per year. It is increasingly recognized that OSA may also have substantial economic consequences. Specifically, there is accumulating evidence implicating OSA as an important contributor to work disability (including absenteeism, presenteeism) and work-related injuries. This review summarizes the current state of knowledge in these two areas.

Entities:  

Mesh:

Year:  2015        PMID: 25940253     DOI: 10.1378/chest.14-1949

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  17 in total

1.  [Stimulation for sleep apnea : Targeting the hypoglossal nerve in the treatment of patients with OSA].

Authors:  C Heiser; B Hofauer
Journal:  HNO       Date:  2018-09       Impact factor: 1.284

Review 2.  [Hypoglossal nerve stimulation in patients with CPAP failure : Evolution of an alternative treatment for patients with obstructive sleep apnea].

Authors:  C Heiser; B Hofauer
Journal:  HNO       Date:  2017-02       Impact factor: 1.284

Review 3.  Diagnosis and treatment of obstructive sleep apnea in adults.

Authors:  Cheryl R Laratta; Najib T Ayas; Marcus Povitz; Sachin R Pendharkar
Journal:  CMAJ       Date:  2017-12-04       Impact factor: 8.262

4.  Long-term effects of solriamfetol on quality of life and work productivity in participants with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea.

Authors:  Terri E Weaver; Jean-Louis Pepin; Richard Schwab; Colin Shapiro; Jan Hedner; Mansoor Ahmed; Nancy Foldvary-Schaefer; Patrick J Strollo; Geert Mayer; Kathleen Sarmiento; Michelle Baladi; Morgan Bron; Patricia Chandler; Lawrence Lee; Atul Malhotra
Journal:  J Clin Sleep Med       Date:  2021-10-01       Impact factor: 4.324

5.  Implementation of a computer-guided consultation in the assessment of suspected obstructive sleep apnoea syndrome.

Authors:  Biswajit Chakrabarti; Nadia Lewis-Burke; Mike Pearson; Sonya Craig; Lisa Davies; Kim Sheridan; Philip England; Eddie McKnight; Robert Angus
Journal:  ERJ Open Res       Date:  2020-07-27

Review 6.  Risk of Occupational Accidents in Workers with Obstructive Sleep Apnea: Systematic Review and Meta-analysis.

Authors:  Sergio Garbarino; Ottavia Guglielmi; Antonio Sanna; Gian Luigi Mancardi; Nicola Magnavita
Journal:  Sleep       Date:  2016-06-01       Impact factor: 5.849

7.  Activating adenosine A1 receptor accelerates PC12 cell injury via ADORA1/PKC/KATP pathway after intermittent hypoxia exposure.

Authors:  Hong-Fang Mei; Neha Poonit; Yi-Chun Zhang; Chu-Yuan Ye; Hui-Lin Cai; Chen-Yi Yu; Yong-Hai Zhou; Bei-Bei Wu; Jun Cai; Xiao-Hong Cai
Journal:  Mol Cell Biochem       Date:  2018-01-29       Impact factor: 3.396

8.  Forced expiratory volume in one second: A novel predictor of work disability in subjects with suspected obstructive sleep apnea.

Authors:  Mariarita Stendardo; Valeria Casillo; Michela Schito; Licia Ballerin; Francesco Stomeo; Emanuela Vitali; Marco Nardini; Elisa Maietti; Piera Boschetto
Journal:  PLoS One       Date:  2018-07-19       Impact factor: 3.240

9.  A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor.

Authors:  Lawrence P Carter; Jack E Henningfield; Y Grace Wang; Yuan Lu; Debra Kelsh; Bradley Vince; Edward Sellers
Journal:  J Psychopharmacol       Date:  2018-10-01       Impact factor: 4.153

10.  Pressure modification or humidification for improving usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea.

Authors:  Barry Kennedy; Toby J Lasserson; Dariusz R Wozniak; Ian Smith
Journal:  Cochrane Database Syst Rev       Date:  2019-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.